Position in NVS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$305,290
New position
Shares Held
1,948
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#1,124
of 1,603 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EJMK Ventures LLC holds $6,215,423 across 8 Drug Manufacturers - General names. NVS ranks #7 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
7,547 | $1,899,127 | |
| 2 | JNJ |
Johnson & Johnson
|
4,664 | $1,184,516 | |
| 3 | LLY |
ELI LILLY & Co
|
752 | $901,971 | |
| 4 | MRK |
Merck & Co., Inc.
|
5,720 | $735,020 | |
| 5 | AMGN |
Amgen Inc
|
1,587 | $574,684 | |
| 6 | AZN |
Astrazeneca PLC
|
2,167 | $410,906 | |
| 7 | NVS |
Novartis AG
This page
|
1,948 | $305,290 | |
| 8 | PFE |
Pfizer Inc
|
8,468 | $203,909 |
All Filings in NVS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $305,290 | 1,948 | Shares | Sole | 2026-08-06 | |
| No filing history on record for this holder in this stock. | ||||||